Stock 603387 GETEIN BIOTECH, INC
Add to a list
To use this feature you must be a member
Log inSign up

Financials Getein Biotech, Inc

Equities

603387

CNE100002RR9

Medical Equipment, Supplies & Distribution

End-of-day quote Shanghai S.E.
Other stock markets
 18:00:00 2024-04-29 EDT 		5-day change 1st Jan Change
9.39 CNY +1.84% Intraday chart for Getein Biotech, Inc +3.87% -14.64%
04-29 Getein Biotech, Inc Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-29 Getein Biotech, Inc Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 4,942 6,002 8,911 7,254 6,339 5,579
Enterprise Value (EV) 1 3,911 4,960 7,900 6,169 5,773 5,309
P/E ratio 19.8 x 17.7 x 29.3 x 18.2 x 12.8 x 20 x
Yield 1.54% 1.74% 1.05% 1.7% 2.72% -
Capitalization / Revenue 7.2 x 6.2 x 7.93 x 5.18 x 3.48 x 4.07 x
EV / Revenue 5.7 x 5.12 x 7.03 x 4.4 x 3.17 x 3.88 x
EV / EBITDA 14.8 x 13.4 x 23 x 13.5 x 10.5 x 15 x
EV / FCF 331 x 5.64 x -78.3 x 53.4 x -20.9 x -237 x
FCF Yield 0.3% 17.7% -1.28% 1.87% -4.78% -0.42%
Price to Book 3.67 x 3.69 x 4.82 x 3.45 x 2.55 x 2.18 x
Nbr of stocks (in thousands) 510,419 510,345 510,268 506,279 507,154 507,154
Reference price 2 9.683 11.76 17.46 14.33 12.50 11.00
Announcement Date 19-04-09 20-03-23 21-04-28 22-04-27 23-04-26 24-04-29
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 686.2 968.2 1,123 1,402 1,822 1,369
EBITDA 1 265.2 370.7 342.7 457 549.9 353.8
EBIT 1 240.7 343.3 307.5 409.6 485.9 268.3
Operating Margin 35.08% 35.46% 27.37% 29.22% 26.67% 19.59%
Earnings before Tax (EBT) 1 287.3 396 374 451.6 560 304.9
Net income 1 249.6 339.7 304.7 399 498.9 279.8
Net margin 36.37% 35.08% 27.13% 28.46% 27.38% 20.43%
EPS 2 0.4883 0.6633 0.5969 0.7857 0.9800 0.5500
Free Cash Flow 1 11.81 878.7 -100.8 115.6 -276.2 -22.41
FCF margin 1.72% 90.75% -8.98% 8.24% -15.16% -1.64%
FCF Conversion (EBITDA) 4.45% 237.01% - 25.29% - -
FCF Conversion (Net income) 4.73% 258.69% - 28.96% - -
Dividend per Share 2 0.1494 0.2041 0.1837 0.2429 0.3400 -
Announcement Date 19-04-09 20-03-23 21-04-28 22-04-27 23-04-26 24-04-29
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 1,031 1,042 1,012 1,085 566 270
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 11.8 879 -101 116 -276 -22.4
ROE (net income / shareholders' equity) 19.8% 22.8% 17.9% 19.3% 20.4% 10.5%
ROA (Net income/ Total Assets) 10.6% 12% 8.16% 8.77% 8.91% 4.5%
Assets 1 2,354 2,832 3,732 4,549 5,598 6,215
Book Value Per Share 2 2.640 3.180 3.620 4.150 4.890 5.040
Cash Flow per Share 2 0.2800 1.290 1.580 1.910 1.270 0.9500
Capex 1 111 125 114 180 217 258
Capex / Sales 16.14% 12.89% 10.11% 12.81% 11.94% 18.85%
Announcement Date 19-04-09 20-03-23 21-04-28 22-04-27 23-04-26 24-04-29
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Diagnostic & Testing Substances

1st Jan change Capi.
GETEIN BIOTECH, INC Stock Getein Biotech, Inc
-14.64% 658M
BIOMÉRIEUX Stock bioMérieux
-2.09% 12.56B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD. Stock Shenzhen New Industries Biomedical Engineering Co., Ltd.
-9.59% 7.68B
DIASORIN S.P.A. Stock DiaSorin S.p.A.
-0.26% 5.29B
LANTHEUS HOLDINGS, INC. Stock Lantheus Holdings, Inc.
+21.82% 5.24B
AUTOBIO DIAGNOSTICS CO., LTD. Stock Autobio Diagnostics Co., Ltd.
+0.02% 4.57B
10X GENOMICS, INC. Stock 10x Genomics, Inc.
-50.89% 3.29B
ANDON HEALTH CO., LTD. Stock Andon Health Co., Ltd.
+6.42% 2.6B
VITROLIFE AB Stock Vitrolife AB
-8.63% 2.2B
GUANGZHOU WONDFO BIOTECH CO.,LTD Stock Guangzhou Wondfo Biotech Co.,Ltd
-8.29% 1.79B
Diagnostic & Testing Substances
  1. Stock Market
  2. Equities
  3. 603387 Stock
  4. Financials Getein Biotech, Inc
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW